Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy – GenomeWeb
NMSU Herald |
Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy
GenomeWeb “Through our deep understanding of cancer biology and emerging research, we recognize the importance for physicians to know each patient’s biomarker status to help fight their cancer in a more personalized way,” Saurabh Saha, senior vice president … Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion …Markets Insider Bristol Partners With Illumina On Diagnostic Test To Use With OpdivoForbes |
WBEZ |
Immunotherapy, The Evolution Of Eyebrows, Unconventional Bird Calls. April 13, 2018, Part 2
WBEZ Tumors are masters of disguise. The field of immunotherapy—teaching our immune system to recognize cancer—is burgeoning with solutions to this problem. More content below this sponsor message. The eyes may be the window to the soul, but it’s our … |
Rare Disease Report |
GSK to Transfer Gene Therapy Portfolio to Orchard Therapeutics
Rare Disease Report Mathew Shanley. On Thursday, GlaxoSmithKline (GSK) announced that it will be transferring its portfolio of approved and investigational gene therapies to Orchard Therapeutics in exchange for a 19.9% stake in the company. Under the agreed terms, GSK … Glaxo to Sell Rare Disease Gene Therapies to Private BiotechZacks.com Orchard Therapeutics to buy GSK’s rare disease gene therapy portfolioPharmaceutical Business Review Strategic agreement to strengthen rare disease gene therapy portfolioHospital Healthcare Europe Zacks all 100 news articles » |
Genetic Engineering & Biotechnology News |
True CRISPR: A Genetic Genre with Novel Twists
Genetic Engineering & Biotechnology News CRISPR truth is stranger than CRISPR fiction, where the revolutionary gene-editing technology is being exploited as a fairly conventional plot device. In an X Files season finale, aliens weaponize CRISPR to attack the human immune system. In Change … CRISPR From ‘Rampage’ Is Real & Its Effects Could Be Even More Terrifying Than In The MovieBustle Is CRISPR Going to Save Our Food Supply?Sanvada Tech News (blog) Podcast: The Gene-Editing Company That Didn’t Need CRISPRhcanews.com Fortune –MENAFN.COM –UPI.com all 13 news articles » |
|
2 Day Seminar: FDA’s Regulation of Regenerative Medicine including: Stem Cell Treatments / Tissue Engineering …
Business Wire (press release) It will also provide the few examples of FDA approved use of stem cells in medicine and what is needed for the field to progress. For example, in 2006, the U.S. FDA implemented regulations governing the use of human cells, tissues, and cellular and … |